TransCode Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
TransCode Therapeutics, Inc.‘s stocks are currently a part of 4 hedge funds’ portfolios, which represents 0.16% of the total amount of its stocks outstanding. This makes up a total of 20.90K shares of TransCode Therapeutics, Inc.. Compared to the previous quarter, the number fell by -93.94% or -324.30K shares fewer. As for the holding position changes, 25% (1) of current hedge fund investors increased the number of shares held, 50% (2) of current holders sold a part of the shares held, and 175% (7) closed the holdings completely.
Hedge funds holding TransCode Therapeutics (Q3 2021 – Q1 2023)
| Q3 2021 | 16 |
|---|---|
| Q4 2021 | 14 |
| Q1 2022 | 12 |
| Q2 2022 | 12 |
| Q3 2022 | 11 |
| Q4 2022 | 18 |
| Q1 2023 | 4 |
Hedge funds changes in TransCode Therapeutics positions (Q3 2021 – Q1 2023)
| Q3 2021 | 16 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2021 | 3 | 5 | 1 | 5 | 0 |
| Q1 2022 | 0 | 4 | 4 | 2 | 2 |
| Q2 2022 | 2 | 2 | 2 | 2 | 4 |
| Q3 2022 | 0 | 0 | 3 | 1 | 7 |
| Q4 2022 | 13 | 2 | 0 | 5 | -2 |
| Q1 2023 | 0 | 1 | 2 | 7 | -6 |
Top 50 hedge fund holders of TransCode Therapeutics, Inc. (NASDAQ:RNAZ)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| AIGH CAPITAL MANAGEMENT LLC | 1.41M | 1.28M | 0.441% |
| WORTH VENTURE PARTNERS, LLC | 357K | 324.15K | 0.219% |
| VANGUARD GROUP INC | 220K | 200.11K | 0.000% |
| REDMOND ASSET MANAGEMENT, LLC | 100K | 90.87K | 0.037% |
| GEODE CAPITAL MANAGEMENT, LLC | 84K | 76.54K | 0.000% |
| STATE STREET CORP | 23K | 21.01K | 0.000% |
| K.J. HARRISON & PARTNERS INC | 22K | 19.98K | 0.008% |
| BLACKROCK INC. Larry Fink | 17K | 15.33K | 0.000% |
| SHAY CAPITAL LLC | 17K | 15.06K | 0.004% |
| ACT CAPITAL MANAGEMENT, LLC | 7K | 6.5K | 0.010% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 6K | 5.50K | 0.000% |
| RENAISSANCE TECHNOLOGIES LLC Jim Simons | 0 | 0 | 0.000% |